NeoBiotechnologies

NeoBiotechnologies Antibodies

Licensing as well as developing new Hybridoma Clones secreting monoclonal antibodies to a wide variety of human proteins with an ultimate goal to cover the entire human proteome. Antibody products are available for various applications through our OEM-partners. Presently, the company is holding more than 1,000 hybridomas.

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.